Fundamental Analysis of CARDLYTICS INC(NASDAQ:CDLX) stock

Fundamental Rating

Taking everything into account, CDLX scores 1 out of 10 in our fundamental rating. CDLX was compared to 92 industry peers in the Media industry. CDLX has a bad profitability rating. Also its financial health evaluation is rather negative. CDLX does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

CDLX had negative earnings in the past year.

CDLX had a negative operating cash flow in the past year.

CDLX had negative earnings in each of the past 5 years.

CDLX had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -28.69%, CDLX is not doing good in the industry: 86.81% of the companies in the same industry are doing better.

CDLX has a Return On Equity of -73.01%. This is in the lower half of the industry: CDLX underperforms 78.02% of its industry peers.

		Industry Rank	Sector Rank
ROA	-28.69%
ROE	-73.01%
ROIC	N/A

ROA(3y)-33.65%

ROA(5y)-24.34%

ROE(3y)-112.81%

ROE(5y)-77.12%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CDLX's Gross Margin of 53.56% is fine compared to the rest of the industry. CDLX outperforms 67.03% of its industry peers.

In the last couple of years the Gross Margin of CDLX has grown nicely.

The Profit Margin and Operating Margin are not available for CDLX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	53.56%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.57%

GM growth 5Y2.94%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CDLX does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, CDLX has more shares outstanding

Compared to 5 years ago, CDLX has more shares outstanding

Compared to 1 year ago, CDLX has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -2.28, we must say that CDLX is in the distress zone and has some risk of bankruptcy.

CDLX has a worse Altman-Z score (-2.28) than 83.52% of its industry peers.

A Debt/Equity ratio of 1.01 is on the high side and indicates that CDLX has dependencies on debt financing.

The Debt to Equity ratio of CDLX (1.01) is worse than 62.64% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.01
Debt/FCF	N/A
Altman-Z	-2.28

ROIC/WACCN/A

WACC5.27%

2.3 Liquidity

CDLX has a Current Ratio of 1.77. This is a normal value and indicates that CDLX is financially healthy and should not expect problems in meeting its short term obligations.

The Current ratio of CDLX (1.77) is better than 64.84% of its industry peers.

CDLX has a Quick Ratio of 1.77. This is a normal value and indicates that CDLX is financially healthy and should not expect problems in meeting its short term obligations.

CDLX's Quick ratio of 1.77 is fine compared to the rest of the industry. CDLX outperforms 64.84% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.77
Quick Ratio	1.77

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CDLX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.53%, which is quite impressive.

CDLX shows a small growth in Revenue. In the last year, the Revenue has grown by 3.59%.

CDLX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.46% yearly.

EPS 1Y (TTM)67.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1600%

Revenue 1Y (TTM)3.59%

Revenue growth 3Y18.27%

Revenue growth 5Y15.46%

Sales Q2Q%-15.12%

3.2 Future

CDLX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.70% yearly.

Based on estimates for the next years, CDLX will show a decrease in Revenue. The Revenue will decrease by -3.80% on average per year.

EPS Next Y-91%

EPS Next 2Y-0.7%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-14.39%

Revenue Next 2Y-3.8%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CDLX. In the last year negative earnings were reported.

Also next year CDLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-0.7%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CDLX does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CARDLYTICS INC

NASDAQ:CDLX (11/7/2024, 11:18:24 AM)

3.655

-1.56 (-29.85%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap182.17M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-28.69%
ROE	-73.01%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	53.56%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.57

Health

		Industry Rank	Sector Rank
Debt/Equity	1.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.77
Quick Ratio	1.77
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)67.53%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y-91%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)3.59%

Revenue growth 3Y18.27%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

CARDLYTICS INC (CDLX)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens